tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

Nurix Therapeutics Inc

NRIX
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
23.210USD
-0.370-1.57%
์ข…๊ฐ€ย 07-31 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
2.41B์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

Nurix Therapeutics Inc

23.210
-0.370-1.57%
๊ฐœ์š”
๊ธˆ์œต
ํ† ๋ก 
๋ถ„์„
ํšŒ์‚ฌ
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ

๊ฐœ์š”

๊ธˆ์œต

ํ† ๋ก 

๋ถ„์„

ํšŒ์‚ฌ

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ

NRIX ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Nurix Therapeutics Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

Nurix Therapeutics Inc ์‹ค์  ๋ฐœํ‘œ์ผ

์ตœ์‹  ์ถœ์‹œ
Jul 9, 2026
EPS / ์˜ˆ์ƒ
-0.81/-0.72
์ˆ˜์ต / ์˜ˆ์ƒ
9.04M/16.17M
์˜ˆ์ •๋œ ์‹ค์  ๋ฐœํ‘œ ์ผ์ • ๋ณด๊ธฐ >>
์ฃผ๊ธฐ
FY2025 ์žฌ๋ฌด์ œํ‘œ
์ˆ˜์ต(YoY)
83.98M
53.95%
EPS(YoY)
-3.05
-5.81%
์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€
BUY
2026/08/02
๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
YOY
๋นˆ ํ–‰ ์ˆจ๊ธฐ๊ธฐ
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
-55.56%-0.81
-17.44%-0.79
-10.09%-0.82
-52.66%-1.03
27.44%-0.52
10.82%-0.67
2.60%-0.75
1.07%-0.67
-59.61%-0.71
-0.30%-0.76
11.41%-0.77
---0.68
---0.45
---0.75
---0.87
---2.85
----
----
----
----
์ˆ˜์ต
-79.47%9.04M
-66.12%6.25M
2.21%13.58M
-37.29%7.89M
264.34%44.06M
11.26%18.45M
-12.37%13.28M
-31.84%12.59M
-60.58%12.09M
30.74%16.59M
123.49%15.16M
71.13%18.47M
168.33%30.68M
31.85%12.69M
-8.29%6.78M
5.26%10.79M
61.22%11.43M
92.00%9.62M
10.57%7.40M
150.97%10.25M
์ˆœ์ด์ต
-106.00%-89.53M
-54.70%-87.17M
-33.60%-78.22M
-76.53%-86.42M
2.43%-43.46M
-35.73%-56.35M
-39.55%-58.55M
-32.38%-48.96M
-83.49%-44.55M
-1.93%-41.52M
10.19%-41.96M
19.09%-36.98M
46.53%-24.28M
4.23%-40.73M
-23.91%-46.72M
-58.52%-45.71M
-72.09%-45.40M
-75.21%-42.53M
-89.32%-37.70M
-55.72%-28.84M
์ˆœ์ด์ต๋ฅ 
-903.59%-990.10%
-356.60%-1394.34%
-30.72%-576.13%
-181.50%-1094.77%
73.22%-98.66%
-21.99%-305.38%
-59.25%-440.75%
-94.20%-388.91%
-365.49%-368.39%
22.04%-250.33%
59.81%-276.77%
---200.26%
---79.14%
---321.11%
---688.74%
---419.68%
----
----
----
----
์ด ์ด์ต๋ฅ 
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์ˆ˜์ต
-79.47%9.04M
-66.12%6.25M
2.21%13.58M
-37.29%7.89M
264.34%44.06M
11.26%18.45M
-12.37%13.28M
-31.84%12.59M
-60.58%12.09M
30.74%16.59M
123.49%15.16M
71.13%18.47M
168.33%30.68M
31.85%12.69M
-8.29%6.78M
5.26%10.79M
61.22%11.43M
92.00%9.62M
10.57%7.40M
150.97%10.25M
์˜์—… ์ด์ต
-94.95%-94.20M
-47.14%-92.50M
-28.52%-83.09M
-67.34%-91.39M
0.45%-48.32M
-39.02%-62.86M
-42.62%-64.66M
-36.49%-54.61M
-81.36%-48.54M
-5.28%-45.22M
6.89%-45.33M
14.35%-40.01M
41.45%-26.77M
-0.49%-42.95M
-28.29%-48.69M
-61.11%-46.72M
-73.07%-45.72M
-74.31%-42.74M
-89.69%-37.95M
-51.09%-29.00M
์ˆœ์ด์ต
-106.00%-89.53M
-54.70%-87.17M
-33.60%-78.22M
-76.53%-86.42M
2.43%-43.46M
-35.73%-56.35M
-39.55%-58.55M
-32.38%-48.96M
-83.49%-44.55M
-1.93%-41.52M
10.19%-41.96M
19.09%-36.98M
46.53%-24.28M
4.23%-40.73M
-23.91%-46.72M
-58.52%-45.71M
-72.09%-45.40M
-75.21%-42.53M
-89.32%-37.70M
-55.72%-28.84M
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
-11.42%456.48M
-1.65%554.39M
-2.03%606.82M
-3.39%440.60M
14.46%515.33M
124.61%563.70M
109.60%619.39M
70.20%456.04M
55.24%450.22M
-12.96%250.97M
-7.21%295.50M
-24.49%267.95M
-5.47%290.01M
2.80%288.33M
2.36%318.45M
-1.00%354.87M
-22.58%306.79M
-9.74%280.48M
4.25%311.12M
-1.55%358.44M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
-4.75%72.02M
2.46%92.20M
-9.79%86.47M
-4.57%82.35M
-6.39%75.61M
2.70%89.99M
10.23%95.85M
40.33%86.30M
11.79%80.78M
35.06%87.62M
23.07%86.96M
-8.90%61.49M
-0.55%72.26M
-1.77%64.88M
6.64%70.66M
33.19%67.50M
55.12%72.67M
37.68%66.05M
48.76%66.26M
23.57%50.68M
์ด ์ž์‚ฐ
-9.47%535.54M
3.43%636.13M
2.81%688.13M
1.73%522.47M
15.76%591.55M
96.70%615.04M
88.23%669.34M
66.65%513.60M
45.75%511.03M
-15.53%312.67M
-14.68%355.60M
-32.90%308.19M
-11.08%350.62M
-15.44%370.15M
-12.59%416.76M
-6.84%459.34M
-23.88%394.31M
10.35%437.72M
20.29%476.77M
19.71%493.07M
๋ถ€์ฑ„ ์ด๊ณ„
-7.67%132.91M
15.74%155.24M
4.94%149.39M
9.85%150.22M
2.58%143.95M
-6.81%134.13M
-8.22%142.35M
83.85%136.74M
54.72%140.34M
49.76%143.93M
37.18%155.10M
-36.32%74.38M
-28.90%90.70M
-27.09%96.10M
-15.92%113.06M
-0.90%116.79M
6.48%127.57M
4.17%131.80M
26.77%134.47M
13.05%117.86M
์ž๋ณธ ์ด๊ณ„
-10.05%402.63M
-0.00%480.89M
2.23%538.75M
-1.22%372.25M
20.75%447.60M
184.99%480.92M
162.85%526.99M
61.18%376.86M
42.62%370.69M
-38.42%168.75M
-33.98%200.49M
-31.74%233.82M
-2.56%259.92M
-10.42%274.05M
-11.28%303.70M
-8.71%342.55M
-33.01%266.74M
13.25%305.92M
17.93%342.30M
21.97%375.22M
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
-52.90%-96.57M
-17.72%-71.91M
-39.14%-67.83M
-36.06%-57.38M
-59.08%-63.16M
-45.62%-61.09M
-282.66%-48.75M
-2.54%-42.18M
-114.98%-39.70M
13.42%-41.95M
170.32%26.69M
11.18%-41.13M
43.89%-18.47M
-13.66%-48.45M
-22.79%-37.95M
-54.50%-46.31M
-4.37%-32.91M
-629.37%-42.63M
-50.92%-30.91M
-388.06%-29.97M
์ˆœํˆฌ์ž
30.07%93.00M
-584.96%-123.83M
100.25%346.00K
336.54%50.48M
154.55%71.50M
-28.10%25.53M
-879.73%-140.82M
-193.69%-21.34M
-399.03%-131.07M
121.02%35.51M
-126.13%-14.37M
136.11%22.77M
1019.85%43.83M
-59.86%16.07M
250.61%55.01M
-415.71%-63.08M
91.66%-4.76M
1777.04%40.03M
70.68%-36.52M
88.68%-12.23M
์ˆœ์žฌ๋ฌดํ™œ๋™
1000.00%66.00K
1256.08%19.98M
17.70%236.01M
-97.48%1.16M
-100.00%6.00K
-9.30%1.47M
2864485.71%200.52M
2586.03%45.77M
950908.00%237.75M
9.66%1.62M
105.19%7.00K
-98.52%1.70M
-94.21%25.00K
-0.47%1.48M
-127.00%-135.00K
7336.02%115.41M
-99.71%432.00K
9.49%1.49M
144.40%500.00K
-99.30%1.55M

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Nurix Therapeutics Inc์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Nurix Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 83.98M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 54.55M์ž…๋‹ˆ๋‹ค.

Nurix Therapeutics Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Nurix Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 606.82M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -2.03์ž…๋‹ˆ๋‹ค.

Nurix Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Nurix Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Nurix Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ 688.13M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 2.81์ž…๋‹ˆ๋‹ค.

Nurix Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Nurix Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Nurix Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” 149.39M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 4.94์ž…๋‹ˆ๋‹ค.

Nurix Therapeutics Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Nurix Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Nurix Therapeutics Inc์˜ ์ด์ž๋ณธ์€ 538.75M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 2.23์ž…๋‹ˆ๋‹ค.

Nurix Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Nurix Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Nurix Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -285.67M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -34.10์ž…๋‹ˆ๋‹ค.

Nurix Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Nurix Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Nurix Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” 147.85M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 157.37์ž…๋‹ˆ๋‹ค.

Nurix Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Nurix Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Nurix Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 238.64M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -50.86์ž…๋‹ˆ๋‹ค.

Nurix Therapeutics Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Nurix Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -3.05์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -5.81์ž…๋‹ˆ๋‹ค.

Nurix Therapeutics Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Nurix Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -264.46M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -36.62์ž…๋‹ˆ๋‹ค.

Nurix Therapeutics Inc์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Nurix Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ -314.90์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 11.26์ž…๋‹ˆ๋‹ค.

Nurix Therapeutics Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Nurix Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -49.63์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 6.74์ž…๋‹ˆ๋‹ค.

Nurix Therapeutics Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Nurix Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -38.96์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -3.15์ž…๋‹ˆ๋‹ค.

Nurix Therapeutics Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Nurix Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -285.67M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -34.10์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ